Cancer

Top Research Topics at Cancer?

The main research concerns discussed in Cancer are Internal medicine, Cancer, Pathology, Surgery and Oncology. The studies on Internal medicine discussed can also contribute to research in the domains of Gastroenterology and Endocrinology. Stage (cooking), Carcinoma, Incidence (epidemiology) and Gynecology are some topics wherein Cancer research discussed in the journal have an impact.

The work tackled in the journal goes beyond the discipline of Carcinoma as it also encompasses Breast carcinoma. Most of the Pathology studies addressed also intersect with Adenocarcinoma. The studies tackled, which mainly focus on Surgery, apply to Radiology as well.

It holds forums on Oncology that merges themes from other disciplines such as Prostate cancer and Hazard ratio. Cyclophosphamide and Combination chemotherapy are all areas of Chemotherapy tackled in the journal.

• Internal medicine (36.10%)
• Cancer (34.12%)
• Pathology (28.29%)

What are the most cited papers published in the journal?

• Reporting results of cancer treatment. (7119 citations)
• Index for rating diagnostic tests (6464 citations)
• “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin (2667 citations)

Research areas of the most cited articles at Cancer:

The most cited publications mainly tackle studies in Cancer, Internal medicine, Surgery, Pathology and Carcinoma. While the primary focus in the journal papers is Cancer, they also dissect topics surrounding Incidence (epidemiology) and Epidemiology as a whole. The published papers hold forums on Internal medicine that merge themes from other disciplines such as Gastroenterology, Endocrinology and Oncology.

What topics the last edition of the journal is best known for?

• Internal medicine
• Cancer
• Disease

The previous edition focused in particular on these issues:

Cancer primarily focuses on research topics in Internal medicine, Cancer, Oncology, Breast cancer and Hazard ratio. Internal medicine study tackled is connected to the field of Gastroenterology. The concepts on Cancer presented in the journal can also apply to other research fields, including Epidemiology, Young adult, Family medicine, Disease and Radiation therapy.

Oncology research presented in the journal encompasses a variety of subjects, including Adverse effect, Chemotherapy, MEDLINE and Clinical trial. The work on Hazard ratio addressed in the journal expands to the thematically related Proportional hazards model. The journal links adjacent topics like Odds ratio with Logistic regression.

The most cited articles from the last journal are:

• Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative. (23 citations)
• The ever-increasing importance of cancer as a leading cause of premature death worldwide. (19 citations)
• Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana. (15 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Cancer (based on the number of publications) are:

• Carrie Printz (800 papers) published 45 papers at the last edition, 21 less than at the previous edition,
• Hagop M. Kantarjian (300 papers) published 16 papers at the last edition, 7 more than at the previous edition,
• Jorge E. Cortes (171 papers) published 4 papers at the last edition, 1 less than at the previous edition,
• Susan O'Brien (138 papers) published 3 papers at the last edition, 1 more than at the previous edition,
• Gabriel N. Hortobagyi (134 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer (based on the number of publications) are:

• University of Texas MD Anderson Cancer Center (2521 papers) published 91 papers at the last edition, 34 more than at the previous edition,
• Harvard University (1950 papers) published 81 papers at the last edition, 5 more than at the previous edition,
• Memorial Sloan Kettering Cancer Center (1663 papers) published 34 papers at the last edition, 17 less than at the previous edition,
• National Institutes of Health (1087 papers) published 12 papers at the last edition the same number as at the previous edition,
• Mayo Clinic (1046 papers) published 24 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 13.15% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 43.20% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.50% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.69% of all publications and 24.61% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Oncology Research

While this compilation of research topics in oncology provides useful insights for fellow researchers and specialists, it can also serve as a guide for individuals considering a career in this domain. From cancer pathologies to new chemotherapy techniques, there are endless areas in oncology research where you can contribute your intellect and passion.

In order to excel in the field of oncology research, a solid foundation and understanding of nursing principles is usually suggested. Some individuals even opt to gain experience as registered nurses before transitioning into research roles to have a better understanding of patient care and the clinical implications of research findings. If you're considering this pathway, learning {anchor} can provide valuable insights.

Beyond nursing, there are numerous roles in oncology research, ranging from laboratory scientists studying cancer cell biology, to medical doctors conducting clinical trials for new treatments, and public health researchers investigating cancer epidemiology globally. The field is vast and the opportunities are limitless for those passionate about combating cancer.

In conclusion, as the field of oncology research continues to grow and evolve, so do the career opportunities. A career in oncology research is challenging but offers the chance to make significant contributions to improve cancer treatment and patient care.